BrainScope

BrainScope is a medical neurotechnology company based in Bethesda, Maryland, dedicated to enhancing brain health through innovative EEG technology and artificial intelligence. Founded in 2006, the company has over 15 years of experience in transforming brain electrical activity into objective diagnostic insights, particularly for mild traumatic brain injury (mTBI), including concussions and brain bleeds. The company’s proprietary platform utilizes advanced machine and deep learning algorithms to analyze EEG data, providing rapid and cost-effective biomarkers. BrainScope developed the first FDA-cleared AI/machine learning medical device in neurology, which is the only point-of-care technology that objectively assesses head-injured patients. Their product lineup includes the Ahead 200 device, which records and analyzes EEG after head injury, and devices under development for further improving TBI and concussion assessment. BrainScope's technology supports clinical decision-making, helping physicians avoid unnecessary CT scans in minor head injury cases. The company also aims to develop novel biomarkers for various neurological conditions, expanding its impact in the field.

• Employees 30
• Founded 2010
• Annual Revenue $12500000
• Total Funding $81900000